These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24855162)

  • 1. Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different.
    Goudie RJ; Lunn D; Hovorka R; Murphy HR
    Diabetes Care; 2014 Jun; 37(6):e121-2. PubMed ID: 24855162
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.
    Mathiesen ER; Kinsley B; Amiel SA; Heller S; McCance D; Duran S; Bellaire S; Raben A;
    Diabetes Care; 2007 Apr; 30(4):771-6. PubMed ID: 17392539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study.
    Heller S; Damm P; Mersebach H; Skjøth TV; Kaaja R; Hod M; Durán-García S; McCance D; Mathiesen ER
    Diabetes Care; 2010 Mar; 33(3):473-7. PubMed ID: 20007944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
    Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K;
    Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin aspart in diabetic pregnancy: state of the art.
    Mathiesen ER
    Womens Health (Lond); 2008 Mar; 4(2):119-24. PubMed ID: 19072511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin detemir in pregnancy: a small but significant step forward?
    McElduff A
    Diabetes Care; 2012 Oct; 35(10):1968-9. PubMed ID: 22996181
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
    Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA
    J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin therapy for the treatment of type 1 diabetes during pregnancy.
    Lenhard MJ; Kinsley BT
    J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1270-5. PubMed ID: 24224883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnant women with type 1 diabetes mellitus treated by glargine insulin.
    Al-Shaikh AA
    Saudi Med J; 2006 Apr; 27(4):563-5. PubMed ID: 16598316
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of type 1 diabetes with nocturnal hypoglycemia after desensitization therapy for insulin allergy.
    Kitamoto T; Sakurai K; Tachibana K; Yokoh H; Ishikawa K; Miki T; Yokote K
    Diabetes Care; 2013 Jul; 36(7):e89. PubMed ID: 23801814
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes.
    Hod M; Mathiesen ER; Jovanovič L; McCance DR; Ivanisevic M; Durán-Garcia S; Brøndsted L; Nazeri A; Damm P
    J Matern Fetal Neonatal Med; 2014 Jan; 27(1):7-13. PubMed ID: 23617228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus.
    Bernasko J
    J Matern Fetal Neonatal Med; 2007 Feb; 20(2):125-32. PubMed ID: 17437210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes.
    Holstein A; Plaschke A; Egberts EH
    Diabet Med; 2003 Sep; 20(9):779-80. PubMed ID: 12925063
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive Glycemic Treatment During Type 1 Diabetes Pregnancy: A Story of (Mostly) Sweet Success!
    Murphy HR
    Diabetes Care; 2018 Aug; 41(8):1563-1571. PubMed ID: 29936423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus.
    Gottlieb PA; Frias JP; Peters KA; Chillara B; Garg SK
    Treat Endocrinol; 2002; 1(4):235-40. PubMed ID: 15799217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
    Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
    Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glargine in pregnant patients with Type 1 diabetes.
    Tahrani AA; Varughese GI; Wilkins JD; Taylor SE; Hanna FW
    Diabet Med; 2008 Jan; 25(1):111-2. PubMed ID: 18199139
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of biosynthetic human insulin with porcine insulin in the blood glucose control of diabetic pregnancy.
    Leiper JM; Paterson KR; Lunan CB; MacCuish AC
    Diabet Med; 1986 Jan; 3(1):49-51. PubMed ID: 2951136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of blood glucose in insulin-dependent diabetic pregnancies and the risks of hypoglycemia: a therapeutic dilemma.
    Rosenn B; Siddiqi TA; Miodovnik M
    Obstet Gynecol Surv; 1995 Jan; 50(1):56-61. PubMed ID: 7891966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.
    Mohn A; Strang S; Wernicke-Panten K; Lang AM; Edge JA; Dunger DB
    Diabetes Care; 2000 Apr; 23(4):557-9. PubMed ID: 10857953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.